Tag / Solvivo
Pressemeldinger • sep 14, 2016 13:35 CEST
Weifa ASA is pleased to announce the launch of Solvivo® lozenges. With Solvivo® Weifa enters the OTC throat segment, which has had a value growth of 64% last twelve months, and represents a value of MNOK 11 last twelve months (pharmacy purchasing price). This is the fastest growing segment within the Cough & Cold category.